Sponsor Pipeline

ImmuneSensor Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07364513 Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies Type 1 Interferonopathies Recruiting
NCT06026254 A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial Solid Tumor, Adult Active, Not Recruiting
Get alerts when ImmuneSensor Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free